JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 34 No. 2 288-290
© 1993 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sasaki, M.
Right arrow Articles by Masuda, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sasaki, M.
Right arrow Articles by Masuda, K.

Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography in Technetium-99m-Hydroxymethylenediphosphate Negative Bone Tumors

Masayuki Sasaki, Yuichi Ichiya, Yasuo Kuwabara, Makoto Otsuka, Toshimitsu Fukumura, Yasuhiro Kawai, Hirohumi Koga and Kouji Masuda

Department of Radiology, Faculty of Medicine, Kyushu University, Higashi-ku, Fukuoka, Japan

Correspondence: For correspondence or reprints contact Masayuki Sasaki, MD, Department of Radiology, Faculty of Medicine. Kyushu University, 3-1-1 Maidashi, Higashiku, Fukuoka 812, Japan.

ABSTRACT

We have encountered two cases of bone tumors with high 18F-fluorodeoxyglucose (FDG) uptake and negative 99mTc-HMDP bone scintigraphy, including a patient with myeloma and a patient with a metastatic bone tumor from esophageal cancer. Bone scintigraphy with a 99mTc-phosphate complex reflects osteoblastic activity in the bone tissue surrounding the tumor, whereas the accumulation of FDG is associated with the metabolic activity of the tumor itself. An FDG-PET study can therefore be used as a complementary study for the detection and follow-up of bone tumors when a 99mTc-phosphate bone scintigram is negative.




This article has been cited by other articles:


Home page
RadiologyHome page
E. J. C. Angtuaco, A. B. T. Fassas, R. Walker, R. Sethi, and B. Barlogie
Multiple Myeloma: Clinical Review and Diagnostic Imaging
Radiology, April 1, 2004; 231(1): 11 - 23.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
M. Schulte, D. Brecht-Krauss, B. Heymer, A. Guhlmann, E. Hartwig, M. R. Sarkar, C. G. Diederichs, A. V. Baer, J. Kotzerke, and S. N. Reske
Grading of Tumors and Tumorlike Lesions of Bone: Evaluation by FDG PET
J. Nucl. Med., October 1, 2000; 41(10): 1695 - 1701.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1993 by the Society of Nuclear Medicine.